Natalie Vinkeles Melchers, Wilma Stolk and Luc Coffeng from the Erasmus MC (Department of Public Health) were invited to the World Health Organization (WHO), Department of Neglected Tropical Diseases, to discuss their work on a modeling study on the impact of ivermectin on skin and eye disease due to onchocerciasis with projections up to 2025. Drs. Vinkeles Melchers presented her recent work, and showed an expanded disease framework within the individual-based mathematical ONCHOSIM model. She used the disease module to predict trends in the prevalence of onchocercal eye and skin disease during a 25-year time frame since start of MDA. Predicted prevalence was projected for various clinical manifestations due to onchocerciasis; reversible conditions (itch and reactive skin disease) and irreversible manifestations (skin atrophy, depigmentation, hanging groin, vision loss). The meeting was attended by WHO experts in the field of, among others, onchocerciasis, lymphatic filariasis, Chagas, and was deemed very successful.
On Thursday 11th May, the RGHI held a special session at the Lowlands Health Economics Study Group (lolaHESG) 2017. Four papers were presented on various topics by members of all three research groups (iBMG, Public Health & ISS) such as Universal Health Coverage in Indonesia, Health Insurance in Nigeria, Child Marriages in Bangladesh and Neonatal mortality. There was a lively discussion after each of the presentations, which led to useful feedback for all participants.
Photo: From left-to-right. Chairman: Eddy van Doorslaer. Speakers: Sofia Trommlerova, Igna Bonfrer, Tanja Houweling, Ahmed Fuady.
This week, in Paris the international climate conference COP21 takes place. In June, the Lancet Commission on Health and Climate Change launched a seminal research report, which underscores that “responding to climate change could be the biggest global health opportunity of the 21st century.” The report provides key policy recommendations for governments to take action in the next five years.
Measuring Impact and Having Impact are not always the same thing. On the occasion of the honorary doctorate awarded this week to prof. Paul Gertler at Erasmus University, a core of topresearchers in the field of impact evaluations in health gathered in the Erasmus Pavillion for a special international conference devoted to innovations in global health financing.
Measuring Impact and Having Impact are not always the same thing. On the occasion of the honorary doctorate to Paul Gertler, one of the world’s best known researchers on impact evaluations in health, RGHI co-organizes a one-day seminar on state-of-the-art questions around evaluating health financing strategies and health impact.